BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Liu Q, Zhu Y, Zhang S, Peng Q, Strickland AL, Zheng W, Zhou F. PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance. CMAR 2021;Volume 13:9157-65. [DOI: 10.2147/cmar.s337271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, Molberg K, Carrick K, Niu S, Rivera Colon G, Gwin K, Lewis C, Zheng W, Castrillon DH, Lucas E. Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma. Mod Pathol 2022;35:1955-65. [PMID: 35804040 DOI: 10.1038/s41379-022-01131-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Beyer S, Müller L, Mitter S, Keilmann L, Meister S, Buschmann C, Kraus F, Topalov NE, Czogalla B, Trillsch F, Burges A, Mahner S, Schmoeckel E, Löb S, Corradini S, Kessler M, Jeschke U, Kolben T. High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer. J Cancer Res Clin Oncol 2022. [PMID: 36068443 DOI: 10.1007/s00432-022-04271-z] [Reference Citation Analysis]
3 Salem RA, Nabegh LM, Abu-zeid RM, Abd Raboh NM, El-rashedy M. Evaluation of Programmed Death Ligand-1 Immunohistochemical Expression and Tumor-Infiltrating Lymphocytes in Different Types of Endometrial Carcinoma. Open Access Maced J Med Sci 2022;10:702-8. [DOI: 10.3889/oamjms.2022.9195] [Reference Citation Analysis]